N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure
- 25 July 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 45 (32) , 9906-9918
Abstract
The key pathogenic event in the onset of Alzheimer's disease (AD) is believed to be the aggregation of the β-amyloid (Aβ) peptide into toxic oligomers. Molecules that interfere with this process may therefore act as therapeutic agents for the treatment of AD. N-Methylated peptides (meptides) are a general class of peptide aggregation inhibitors that act by binding to one face of the aggregating peptide but are unable to hydrogen bond on the other face, because of the N-methyl group replacing a backbone NH group. Here, we optimize the structure of meptide inhibitors of Aβ aggregation, starting with the KLVFF sequence that is known to bind to Aβ. We varied the meptide length, N-methylation sites, acetylation, and amidation of the N and C termini, side-chain identity, and chirality, via five compound libraries. Inhibitor activity was tested by thioflavin T binding, affinity chromatography, electron microscopy, and an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide toxicity assay. We found that inhibitors should have all d chirality, have a free N terminus but an amidated C terminus, and have large, branched hydrophobic side chains at positions 1−4, while the side chain at position 5 was less important. A single N-methyl group was necessary and sufficient. The most active compound, d-[(chGly)-(Tyr)-(chGly)-(chGly)-(mLeu)]-NH2, was more active than all previously reported peptide inhibitors. Its related non-N-methylated analogues were insoluble and toxic.Keywords
This publication has 8 references indexed in Scilit:
- The Diastereomeric Assembly of Polylysine Is the Low-Volume Pathway for Preferential Formation of β-Sheet AggregatesJournal of the American Chemical Society, 2004
- Inhibition of β‐amyloid toxicity by short peptides containing N‐methyl amino acidsChemical Biology & Drug Design, 2004
- Stereoselective Interactions of Peptide Inhibitors with the β-Amyloid PeptideJournal of Biological Chemistry, 2003
- A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers DiseaseCurrent Drug Targets, 2003
- Design and characterization of a membrane permeable N‐methyl amino acid‐containing peptide that inhibits Aβ1–40 fibrillogenesisChemical Biology & Drug Design, 2002
- ?-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasmaJournal of Neurobiology, 1999
- A Strategy for Designing Inhibitors of β-Amyloid ToxicityJournal of Biological Chemistry, 1996
- Arrest of -Amyloid Fibril Formation by a Pentapeptide LigandJournal of Biological Chemistry, 1996